Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
News
2013
HAI Europe Calls on EFPIA and PhRMA to Truly Commit to Clinical Trial Data Transparency
LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines
NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries
Long-awaited Steps Towards Affordable Access and Needs-driven Research and Development
Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique
EU-India free trade deal puts millions of lives at risk
La Alianza LAC-Global reconoce el paso dado por el Medicines Patent Pool
2012 Annual Report
2012 Financial Statements
2012
Follow-up on CEWG Report on Research and Development Financing and Coordination 2012
ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
Time for the final push: Say “No” to ACTA – again
EU and U.S. Negotiators Block Broad Support of Low- and Middle-income Countries to Move Towards Binding Health and Development R&D Convention
EU Parliament Says No and No Again to EMA: Independent Groups Echo Decision
Health Activists and Consumers Ask for Greater Public Return on EU Health R&D Spending and a Turn to Needs-driven Innovation
Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs
Civil Society Calls on Members of the European Parliament to Condemn ACTA
Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby
Heading ACTA and Access to Medicines: Flawed Process, Rationale and Agreement
Protect Access to Medicines: Say “No” to ACTA
Business Conduct Guidelines
Complaints Procedure (EN)
Procedimiento de Querellas
Klachtenprocedure (Complaints Procedure – Dutch)
Unlocking the Mysteries of Access to Clinical Trials Data in the EU
Call to EU Leadership on Global Health Research & Development
2011